CN104491695A - 一种治疗黄褐斑的药物组合物 - Google Patents
一种治疗黄褐斑的药物组合物 Download PDFInfo
- Publication number
- CN104491695A CN104491695A CN201410728485.6A CN201410728485A CN104491695A CN 104491695 A CN104491695 A CN 104491695A CN 201410728485 A CN201410728485 A CN 201410728485A CN 104491695 A CN104491695 A CN 104491695A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- pharmaceutical composition
- rhizoma
- curcumae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 29
- 206010008570 Chloasma Diseases 0.000 title claims abstract description 28
- 208000003351 Melanosis Diseases 0.000 title claims abstract description 28
- 239000008280 blood Substances 0.000 claims abstract description 24
- 210000004369 blood Anatomy 0.000 claims abstract description 24
- 239000003814 drug Substances 0.000 claims abstract description 22
- 238000011282 treatment Methods 0.000 claims description 41
- 241000628997 Flos Species 0.000 claims description 13
- 239000002994 raw material Substances 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 claims description 9
- 238000009472 formulation Methods 0.000 claims description 7
- 239000002775 capsule Substances 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 15
- 210000004185 liver Anatomy 0.000 abstract description 15
- 230000001737 promoting effect Effects 0.000 abstract description 12
- 238000000034 method Methods 0.000 abstract description 8
- 230000017531 blood circulation Effects 0.000 abstract description 7
- 229940079593 drug Drugs 0.000 abstract description 7
- 230000001105 regulatory effect Effects 0.000 abstract description 5
- 235000013399 edible fruits Nutrition 0.000 abstract description 3
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 244000236521 Bupleurum rotundifolium Species 0.000 abstract 1
- 235000015221 Bupleurum rotundifolium Nutrition 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 244000163122 Curcuma domestica Species 0.000 abstract 1
- 235000003392 Curcuma domestica Nutrition 0.000 abstract 1
- 240000009138 Curcuma zedoaria Species 0.000 abstract 1
- 235000003405 Curcuma zedoaria Nutrition 0.000 abstract 1
- 244000150195 Cyperus longus Species 0.000 abstract 1
- 235000018109 Cyperus longus Nutrition 0.000 abstract 1
- 244000075634 Cyperus rotundus Species 0.000 abstract 1
- 244000111489 Gardenia augusta Species 0.000 abstract 1
- 235000018958 Gardenia augusta Nutrition 0.000 abstract 1
- 235000018142 Hedysarum alpinum var americanum Nutrition 0.000 abstract 1
- 240000006461 Hedysarum alpinum var. americanum Species 0.000 abstract 1
- 241000212322 Levisticum officinale Species 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 235000005010 Scirpus paludosus Nutrition 0.000 abstract 1
- 241000329195 Sparganium erectum Species 0.000 abstract 1
- 235000003373 curcuma longa Nutrition 0.000 abstract 1
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 abstract 1
- 239000001645 levisticum officinale Substances 0.000 abstract 1
- 235000013976 turmeric Nutrition 0.000 abstract 1
- 235000019509 white turmeric Nutrition 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 24
- 201000010099 disease Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 201000000736 Amenorrhea Diseases 0.000 description 9
- 206010001928 Amenorrhoea Diseases 0.000 description 9
- 231100000540 amenorrhea Toxicity 0.000 description 9
- 208000005171 Dysmenorrhea Diseases 0.000 description 8
- 206010013935 Dysmenorrhoea Diseases 0.000 description 8
- 210000001015 abdomen Anatomy 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 7
- 208000019255 Menstrual disease Diseases 0.000 description 5
- 210000000481 breast Anatomy 0.000 description 5
- 210000000038 chest Anatomy 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- 206010000077 Abdominal mass Diseases 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 208000025747 Rheumatic disease Diseases 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000001815 facial effect Effects 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 210000000232 gallbladder Anatomy 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 210000003127 knee Anatomy 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000002175 menstrual effect Effects 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 230000000552 rheumatic effect Effects 0.000 description 3
- 206010040882 skin lesion Diseases 0.000 description 3
- 231100000444 skin lesion Toxicity 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 2
- 235000007466 Corylus avellana Nutrition 0.000 description 2
- 240000003211 Corylus maxima Species 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 101100117236 Drosophila melanogaster speck gene Proteins 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 206010062049 Lymphocytic infiltration Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 241000013557 Plantaginaceae Species 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010042170 Strangury Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000000680 avirulence Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000001058 brown pigment Substances 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 208000019065 cervical carcinoma Diseases 0.000 description 1
- 230000008576 chronic process Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000000142 dyskinetic effect Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 208000000069 hyperpigmentation Diseases 0.000 description 1
- 230000003810 hyperpigmentation Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002189 macula lutea Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000000216 zygoma Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/902—Sparganiaceae (Bur-reed family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明属于医药技术领域,具体涉及一种治疗黄褐斑的药物组合物。所述药物组合物包括如下组分:柴胡、丹参、川芎、生地、当归、栀子、郁金、三棱、红花、莪术、香附、甘草。本发明药物组合物具有疏肝理气、活血化瘀的功效,使用本发明所述药物组合物治疗黄褐斑疗效确切,安全可靠,可作为治疗黄褐斑的有效方法。
Description
技术领域
本发明属于医药技术领域,具体涉及一种治疗黄褐斑的药物组合物。
背景技术
随着社会发展,物质水平不断提高,人们对美的追求也逐渐加强,尤其是女性求美意识明显增强,而黄褐斑作为当前损容性疾病之一,虽然皮损不能带给患者疼痛、瘙痒等不适,但其严重影响仪表,常给患者带来一定的社会压力和心理压力,这是当前医学界和美容界都非常关注的问题。
黄褐斑是一种主要以颜面部出现局限性淡褐色或褐色色素沉着障碍性皮肤病。多发于前额、两颧、颊部、鼻部以及口周等处,皮损为淡褐色至深褐色色素沉着斑,常对称分布,无脱屑,边界清楚,表面光滑,局部无疼痛及瘙痒,日晒后色素加深,一般多发于中年女性及妊娠期的妇女。其证候分类包括气滞血瘀型:颜面出现黄褐色斑片,腰膝酸软,或急躁易怒,胸胁胀痛。舌质暗,苔薄白,脉沉细。肝肾阴虚型:黄斑褐黑,伴腰膝酸软,怠倦无力,身体羸瘦。舌红,苔少,脉沉细。
目前西医对此病的治疗并不十分理想,且副作用较大。中医对此病的治疗积累了丰富的经验,疗效较为确切,且副作用小,让越来越多的患者选择中医中药治疗此病,因此,加强此病在中医中药方面的研究与探索,能更确切的改善患者病情,更好的为患者服务。
发明内容
本发明提供了一种治疗黄褐斑的新的药物组合物,该药物组合物疗效好,毒副作用小,它由以下原料制得:柴胡、丹参、川芎、生地、当归、栀子、郁金、三棱、红花、莪术、香附、甘草。
本发明所述药物组合物中,所述柴胡,苦,微寒。归肝、胆经。和解表里,疏肝,升阳。用于感冒发热,寒热往来,胸胁胀痛,月经不调,子官脱垂,脱肛。
丹参,苦,微寒。归心、肝经。祛瘀止痛,活血通经,清心除烦。用于月经不调,经闭痛经,癥瘕积聚,胸腹刺痛,热痹疼痛,疮疡肿痛,心烦不眠;肝脾肿大,心绞痛。
川芎,辛,温。归肝、胆、心包经。活血行气,祛风止痛。用于月经不调,经闭痛经,癥瘕腹痛,胸胁刺痛,跌扑肿痛,头痛,风湿痹痛。
生地,别名生地黄,为玄参科植物地黄的块根。甘,寒。归心、肝、肾经。清热凉血,养阴,生津。用于热病舌绛烦渴,阴虚内热,骨蒸劳热,内热消渴,吐血,衄血,发斑发疹。
当归,甘、辛,温。归肝、心、脾经。补血活血,调经止痛,润肠通便。用于血虚萎黄,眩晕心悸,月经不调,经闭痛经,虚寒腹痛,肠燥便秘,风湿痹痛,跌扑损伤,痈疽疮疡。酒当归活血通经。用于经闭痛经,风湿痹痛,跌扑损伤。
栀子,苦,寒。归心、肺、三焦经。果实:泻火除烦,清热利尿,凉血解毒。用于热病心烦,黄疸尿赤,血淋涩痛,血热吐衄,目赤肿痛,火毒疮疡;外治扭挫伤痛。根:泻火解毒,清热利湿,凉血散瘀。用于传染性肝炎,跌打损伤,风火牙痛。
郁金,辛、苦,寒。归肝、心、肺经。行气化瘀,清心解郁,利胆退黄。用于经闭痛经,胸腹胀痛、刺痛,热病神昏,癫痫发狂,黄疸尿赤。
三棱,味辛,涩,凉;肝;脾经。破血行气;消积止痛。主症瘕痞块;瘀滞经闭;痛经;食积胀痛;跌年伤痛。
红花,辛,温。归心、肝经。活血通经,散瘀止痛。用于经闭,痛经,恶露不行,癥瘕痞块,跌扑损伤,疮疡肿痛。
莪术,辛、苦,温。归肝、脾经。行气破血,消积止痛。用于燀瘕痞块,瘀血经闭,食积胀痛;早期宫颈癌。
香附,辛、微苦、微甘,平。归肝、脾、三焦经。行气解郁,调经止痛。用于肝郁气滞,胸、胁、脘腹胀痛,消化不良,胸脘痞闷,寒疝腹痛,乳房胀痛,月经不调,经闭痛经。
甘草,甘,平。归心、肺、脾、胃经 。补脾益气,清热解毒,祛痰止咳,缓急止痛,调和诸药。用于脾胃虚弱,倦怠乏力,心悸气短,咳嗽痰多,脘腹、四肢挛急疼痛,痈肿疮毒,缓解药物毒性、烈性。
本发明为纯中药制剂,对人体特别是对肝脏无毒性。本发明药物组合物遵循扶正祛邪,标本兼治的治疗原则,诸药合用,共奏疏肝理气、活血化瘀之功效。为解决其技术问题所采用的技术方案是所述治疗黄褐斑的药物组合物,由下列重量份配比的药物原料组成:柴胡8-20份、丹参10-20份、川芎5-15份、生地10-20份、当归10-20份、栀子3-12份、郁金10-20份、三棱3-9份、红花5-15份、莪术3-9份、香附3-9份、甘草3-12份。
本发明的优选技术方案是,所述本发明药物组合物由以下重量份的原料制得:柴胡14份、丹参15份、川芎10份、生地15份、当归15份、栀子8份、郁金15份、三棱6份、红花10份、莪术6份、香附6份、甘草8份。
本发明还提供了所述药物组合物的制备方法,具体如下:取处方中各味药材的干药原料,除去杂质,洗净,干燥,用冷水浸泡30min,煮沸10min,滤除药渣取汁,药渣重复上述工艺一次,混合两次滤液冷却后备用。本领域技术人员可以在此基础上加入辅料用常规制剂工艺即可制得临床上常用的各种剂型。为了更好地方便患者使用本发明的药物组合物,本发明的药物组合物可以按照常规工艺制备成临床上常用的口服制剂,如汤剂、水剂、合剂、片剂、胶囊剂、颗粒剂或散剂等。更优选的是,本发明药物组合物按照常规制备工艺制备成汤剂。所制备的汤剂中,每毫升药液含生药量0.1g,1剂/天,用于治疗黄褐斑时,早晚饭后各温服1次,每次150mL。
本发明还请求保护上述药物组合物在制备治疗黄褐斑特别是在制备治疗气滞血瘀型黄褐斑药物中的用途。在通过本发明药物组合物的安全性评价后,选用临床病例观察可知所治疗的103例气滞血瘀型黄褐斑患者中,治疗组的治疗总有效率为96.12%,治疗组的治疗总有效率明显高于对照组,P<0.05,具有统计学意义。结果表明,本发明的药物组合物对治疗气滞血瘀型黄褐斑患者有极其显著疗效。治疗组随访1年无一例复发、治疗期间无不良反应。由此说明本发明药物组合物组方后达到了疏肝理气、活血化瘀的目的,起到了治疗黄褐斑特别是治疗气滞血瘀型黄褐斑的显著效果。
本发明药物组合物制备工艺简单易操作、原药易得、成本低廉,遵循中医的处方用药原则,不良反应和副作用显著降低,安全系数高,经临床应用验证,其疗效确切,药性平和,未出现毒副作用及严重不良反应,可以较好地治疗黄褐斑特别是气滞血瘀型黄褐斑。使用本发明所述药物组合物治疗黄褐斑疗效确切,安全可靠,可作为治疗黄褐斑的有效方法。
具体实施方式
以下通过具体实施例进一步描述本发明,但是本发明不仅仅限于以下具体实施例。在本发明的范围内或者在不脱离本发明的内容、精神和范围内,对本发明进行的变更、组合或替换,对于本领域的技术人员来说是显而易见的,且包含在本发明的范围之内。
实施例1
按以下重量份称取本发明各原料:柴胡14份、丹参15份、川芎10份、生地15份、当归15份、栀子8份、郁金15份、三棱6份、红花10份、莪术6份、香附6份、甘草8份。
实施例2
按以下重量份称取本发明各原料:柴胡8份、丹参10份、川芎5份、生地10份、当归10份、栀子3份、郁金10份、三棱3份、红花5份、莪术3份、香附3份、甘草3份。
实施例3
按以下重量份称取本发明各原料:柴胡20份、丹参20份、川芎15份、生地20份、当归20份、栀子12份、郁金20份、三棱9份、红花15份、莪术9份、香附9份、甘草12份。
实施例4
按以下重量份称取本发明各原料:柴胡20份、丹参10份、川芎15份、生地10份、当归20份、栀子3份、郁金20份、三棱3份、红花15份、莪术3份、香附9份、甘草3份。
实施例5
按以下重量份称取本发明各原料:柴胡8份、丹参20份、川芎5份、生地20份、当归10份、栀子12份、郁金10份、三棱9份、红花5份、莪术9份、香附3份、甘草12份。
制备工艺:取处方中各味药材的干药原料,除去杂质,洗净,干燥,用冷水浸泡30min,煮沸10min,滤除药渣取汁,药渣重复上述工艺一次,混合两次滤液,冷却后即得汤剂,每毫升药液含生药量0.1g,1剂/天,用于治疗黄褐斑时,早晚饭后各温服1次,每次150mL。本领域技术人员还可以在此基础上加入辅料用常规制剂工艺即可制得合剂、片剂、胶囊剂、颗粒剂或散剂等常用的口服制剂。
实施例6 本发明药物组合物治疗黄褐斑的临床资料
一、病例资料:选取医院皮肤病科及门诊的符合筛选诊断标准的206例女性气滞血瘀型患者作为研究对象,伴有症状符合:颜面出现黄褐色斑片,腰膝酸软,或急躁易怒,胸胁胀痛。舌质暗,苔薄白,脉沉细。随机分为治疗组和对照组。
治疗组103例,年龄23-48岁,平均年龄(28.3±4.1)岁;病程8个月-9年,平均病程(3.7±2.7)年。对照组103例,年21-46岁,平均年龄(29.1±4.4)岁;病程10个月-9年,平均病程(3.5±2.8)年。两组患者一般资料无明显差异,P>0.05,具有可比性。
二、诊断标准:
1、诊断依据:
1)面部皮损为黑斑,平于皮肤,色如尘垢,淡褐或淡黑,无痒痛。
2)常发生在额、眉、颊、鼻背、唇等颜面部。
3)多见于女子,起病有慢性过程。
4)组织病理检查示表皮中色素过度沉着,真皮中嗜黑素细胞也有较多的色素。可在血管和毛囊周围有少数淋巴细胞浸润。
2、病例选择:
1)年龄在20-55岁之间;
2)无严重内分泌等疾病患者;
3)对治疗药物无过敏史者;
4)无妊娠或哺乳期妇女。
3、剔除和脱落标准
1)受试者依从性差,未按医嘱进行治疗;
2)资料不全,影响疗效或安全性判断者;
3)因不良反应终止用药者;
4)治疗过程中发生过敏反应、严重不良事件及特殊生理变化须终止治疗者;
5)研究过程中不能耐受治疗中途退出者;
6)治疗期间,服用其他治疗药物,有可能干扰研究结果者;
7)参加其他临床试验者。
三、用法用量:
治疗组:取柴胡14g、丹参15g、川芎10g、生地15g、当归15g、栀子8g、郁金15g、三棱6g、红花10g、莪术6g、香附6g、甘草8g,用冷水浸泡30min,煮沸10min,滤除药渣取汁,药渣重复上述工艺一次,混合两次滤液,冷却后取汁300ml(每毫升药液含生药量0.1g),1剂/天,早、晚饭后各温服1次,每次150ml。
对照组:排毒养颜胶囊(国药准字Z53020685)0.8g,每日2次,口服。
两组均以4周为一个疗程,治疗1个疗程后判定疗效。服药期间多食水果、蔬菜,多喝白开水,禁食或少食油炸、辛辣刺激性的食物。
四、疗效标准:
参照中国中西医结合学会皮肤性病专业委员会色素病学组2003年修订的黄褐斑疗效标准。
治愈:肉眼视色斑面积消退大于90%,颜色基本消失。
显效:肉跟视色斑面积消退大于60%,颜色明显变淡。
好转:肉眼视色斑面积消退大于30%.颜色变淡。
无效:肉眼视色斑面积消退小于30%,颜色变化不明显。
总有效率=(治愈+显效+有效)/总例数×100%
五、治疗效果:
治疗组的治疗总有效率为96.12%,对照组为76.70%,可见,治疗组的治疗总有效率明显高于对照组,P<0.05,具有统计学意义,两组均未出现严重的不良反应。具体结果见表1,表明使用本发明所述药物组合物治疗黄褐斑疗效确切,安全可靠,可作为治疗黄褐斑的有效方法。
表1.治疗组和对照组的疗效比较
组别 | 治愈 | 显效 | 有效 | 无效 | 总有效率 |
治疗组 | 44 | 32 | 23 | 4 | 99(96.12%) |
对照组 | 19 | 23 | 37 | 24 | 84(76.70%) |
Claims (7)
1.一种治疗黄褐斑的药物组合物,其特征在于,它由以下原料制得:
柴胡、丹参、川芎、生地、当归、栀子、郁金、三棱、红花、莪术、香附、甘草。
2.如权利要求1所述的药物组合物,其特征在于,它由以下重量份的原料制得:
柴胡8-20份、丹参10-20份、川芎5-15份、生地10-20份、当归10-20份、栀子3-12份、郁金10-20份、三棱3-9份、红花5-15份、莪术3-9份、香附3-9份、甘草3-12份。
3.如权利要求2所述的药物组合物,其特征在于,它由以下重量份的原料制得:
柴胡14份、丹参15份、川芎10份、生地15份、当归15份、栀子8份、郁金15份、三棱6份、红花10份、莪术6份、香附6份、甘草8份。
4.如权利要求1-3任一所述的药物组合物,其特征在于,所述药物组合物是口服制剂。
5.如权利要求3所述的药物组合物,其特征在于,所述口服制剂为汤剂、片剂、胶囊剂、颗粒剂或散剂。
6.如权利要求5所述的药物组合物,其特征在于,所述口服制剂为汤剂。
7.如权利要求1-3任一所述的药物组合物在制备治疗气滞血瘀型黄褐斑药物中的用途。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410728485.6A CN104491695A (zh) | 2014-12-05 | 2014-12-05 | 一种治疗黄褐斑的药物组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410728485.6A CN104491695A (zh) | 2014-12-05 | 2014-12-05 | 一种治疗黄褐斑的药物组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104491695A true CN104491695A (zh) | 2015-04-08 |
Family
ID=52933209
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410728485.6A Pending CN104491695A (zh) | 2014-12-05 | 2014-12-05 | 一种治疗黄褐斑的药物组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104491695A (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104958711A (zh) * | 2015-07-29 | 2015-10-07 | 青岛蓝盛洋医药生物科技有限责任公司 | 一种治疗黄褐斑的药物组合物及其制备方法 |
CN105497783A (zh) * | 2015-12-21 | 2016-04-20 | 暨南大学 | 一种中药制剂在制备治疗气滞血瘀型黄褐斑药物中的用途 |
CN107970373A (zh) * | 2017-12-20 | 2018-05-01 | 南宁多灵生物科技有限公司 | 一种治疗黄褐斑的药物组合物 |
CN109364205A (zh) * | 2018-12-17 | 2019-02-22 | 温州古木生物科技有限公司 | 一种具有皮肤祛斑功效的中药组合物及其水提物和发酵物以及应用 |
CN109621183A (zh) * | 2018-12-05 | 2019-04-16 | 安徽创孚医疗科技有限公司 | 一种美容贴及其使用方法 |
-
2014
- 2014-12-05 CN CN201410728485.6A patent/CN104491695A/zh active Pending
Non-Patent Citations (1)
Title |
---|
叶建洪: "《家庭医疗保健丛书(第一辑)·皮肤病》", 31 May 2003, 广州出版社 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104958711A (zh) * | 2015-07-29 | 2015-10-07 | 青岛蓝盛洋医药生物科技有限责任公司 | 一种治疗黄褐斑的药物组合物及其制备方法 |
CN105497783A (zh) * | 2015-12-21 | 2016-04-20 | 暨南大学 | 一种中药制剂在制备治疗气滞血瘀型黄褐斑药物中的用途 |
CN107970373A (zh) * | 2017-12-20 | 2018-05-01 | 南宁多灵生物科技有限公司 | 一种治疗黄褐斑的药物组合物 |
CN109621183A (zh) * | 2018-12-05 | 2019-04-16 | 安徽创孚医疗科技有限公司 | 一种美容贴及其使用方法 |
CN109364205A (zh) * | 2018-12-17 | 2019-02-22 | 温州古木生物科技有限公司 | 一种具有皮肤祛斑功效的中药组合物及其水提物和发酵物以及应用 |
CN109364205B (zh) * | 2018-12-17 | 2021-09-21 | 温州古木生物科技有限公司 | 一种具有皮肤祛斑功效的中药组合物及其水提物和发酵物以及应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102178911B (zh) | 用于阳虚、痰湿体质人祛风除湿、通络止痛的中药制剂及其制备方法和应用 | |
CN104491695A (zh) | 一种治疗黄褐斑的药物组合物 | |
CN103432559B (zh) | 一种治疗血滞型月经减少及痛经的中药组合物及其制备方法和用途 | |
CN103638451A (zh) | 一种治疗慢性肝炎的中药及其制备方法 | |
CN104491778A (zh) | 一种治疗斑秃的药物组合物 | |
CN104436048A (zh) | 一种中药制剂在制备治疗气滞血瘀型黄褐斑药物中的用途 | |
CN103919966B (zh) | 一种治疗痤疮的药物 | |
CN104042981A (zh) | 一种治疗产后便秘的药剂及制备方法 | |
CN102552520A (zh) | 一种治疗胸痹心痛的活血止痛药物及制备工艺和应用 | |
CN107617081B (zh) | 一种治疗脱发的中药组合物及其制剂与制备方法 | |
CN105497262A (zh) | 一种治疗肝肾阴虚型多囊卵巢综合征的药物组合物 | |
CN105233078A (zh) | 一种用于治疗病毒性肝炎的中药组合物 | |
CN104887950A (zh) | 一种治疗乳痈的中药组合物 | |
CN104352944A (zh) | 一种用于痤疮的药物组合物 | |
CN103735741A (zh) | 一种治疗痛风病的中药组合物 | |
CN103432466A (zh) | 治疗女性盆腔炎的中药组合物及其制备方法 | |
CN102698191A (zh) | 一种消除面部色斑的药物 | |
CN103393757B (zh) | 治疗放射性脑损伤的中药汤剂 | |
CN104825846A (zh) | 一种治疗面神经炎的中药组合物 | |
CN104524463B (zh) | 一种治疗痤疮的药物组合物 | |
CN104689156A (zh) | 一种治疗黄褐斑脾虚湿蕴证的药物制剂及制备方法 | |
CN104138491A (zh) | 一种治疗牙痛的中药及其制法 | |
CN104288643A (zh) | 一种治疗虚劳遗精的药物组合物及其制备方法 | |
CN103301281A (zh) | 一种治疗子宫肌瘤的中药及其制备方法 | |
CN113041333A (zh) | 一种治疗精神分裂症的中药药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150408 |
|
RJ01 | Rejection of invention patent application after publication |